Clinical trial
Adherence to Aromatase Inhibitors: The Role of Partners
NCT02753985 is registered in ClinicalTrials.gov with Abramson Cancer Center at Penn Medicine as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Adherence to Aromatase Inhibitors: The Role of Partners
- Lead sponsor
- Abramson Cancer Center at Penn Medicine
- Phase
- Observational
- Overall status
- Completed
- Start date
- July 31, 2014
- Completion date
- April 22, 2016
- Enrollment
- 40 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
breast cancer survivors